Skip to main content
. 2020 Dec 15;19:1533033820964222. doi: 10.1177/1533033820964222

Figure 1.

Figure 1.

Serum miR-762 was upregulated in patients with NSCLC. (A) The expression level of serum miR-762 was higher in NSCLC patients than in healthy controls. (B) Serum miR-762 effectively discriminated NSCLC patients from healthy controls. (C) Serum miR-762 identified NSCLC patients at the clinical stage I from healthy individuals with high accuracy.